We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

BIONEER

Provides solutions for molecular diagnostics including nucleic acid extraction instruments, real-time PCR instruments... read more Featured Products: More products

Download Mobile App





Bioneer Presents Near-Patient POC Molecular Diagnostic System at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022

Bioneer Corp. More...

(Daejeon, Korea) is demonstrating its state-of-the-art molecular biology products and technologies at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany.

At MEDICA 2022, Bioneer is showcasing the AccuLoader which guides users to load samples into the correct wells of a multi-well plate by scanning each sample barcode and automatically moving the dispensing hole to the correct well. Loading conditions and sample information are easily managed using the included tablet and dedicated AccuLoader application. In addition, users can quickly pool a large number of samples without human error using the pool sample setting, and the sample shield and filter prevent cross-contamination while samples are being loaded. Bioneer is also highlighting the ExiPrep 96 Lite automated nucleic acid extractor with high capacity which has built-in protocols optimized for various kit applications for the extraction of nucleic acid. ExiPrep 96 Lite can extract viral RNA in 30 minutes with the Protonion Viral RNA Kit, which does not contain EtOH to prevent PCR inhibition and rapid extraction speed.

Alongside the ExiPrep 96 Lite, Bioneer is showcasing the ExiStation series of automated molecular diagnostic system composed of the ExiPrep 16 Dx nucleic acid extractor and Exicycler 96 Real-Time PCR. The system configuration is flexible and can connect up to three ExiPrep 16 Dx. The ExiStation 48 is composed of ExiPrep 48Dx nucleic acid extractor and the Exicycler 96 Real-Time PCR. The ExiStation series of automated molecular diagnostic system has been developed with Bioneer’s patented technologies and are adjustable to lab conditions. The ExiStation series are optimized for vacuum-dried premix kits and adapted with four-layer contamination protection for constant test accuracy.

At MEDICA 2022, Bioneer is highlighting its new IRON-qPCR near-patient POC molecular diagnostic system which is fully automated and requires the user to just put the sample in to get the data out. The assays are done within 30 minutes and are suitable for near-patient diagnosis. The IRON-qPCR is also a two-cartridge type instrument with user-friendly operation steps using the touch screen, and can handle up to 40 pathogens at once for syndrome diagnosis. Visitors to Bioneer’s booth at MEDICA 2022 can experience the ExiStation FA 96/384 fully automated molecular diagnostic system that is capable of automated de-capping and capping primary sample tubes inside the system. It does not require negative-pressure facility such as BSC and helps generate consistent results without human error. Visitors can also experience the LH 384 fully automated liquid handler that transfers extracted nucleic acid to PCR preparation. It transfers extracted nucleic acid from 96 well plates to a 96/384 well plate or tubes. With Bioneer’s premix cartridges, user can easily prepare samples for PCR by simply sealing the PCR plate or tubes.

Related Links:
Bioneer Corp.


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
New
Toxoplasma Gondii Test
Toxo IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.